专利检索 ap:("DANIELA ALBERATI" OR "RUBÉN ALVAREZ SÁNCHEZ" OR "KONRAD BLEICHER" OR "ALEXANDER FLOHR" OR "KATRIN GROEBKE ZBINDEN" OR "MATTHIAS KOERNER" OR "BERND KUHN" OR "JENS-UWE PETERS" OR "MARKUS RUDOLPH") AND inv:"DANIELA ALBERATI" 第 1 页

1.

发明申请
NOVEL IMIDAZOPYRIDINES 有权

公开(公告)号：US20110294779A1

公开(公告)日：2011-12-01

申请号：US13151310

申请日：2011-06-02

申请人： DANIELA ALBERATI , RUBÉN ALVAREZ SÁNCHEZ , KONRAD BLEICHER , ALEXANDER FLOHR , KATRIN GROEBKE ZBINDEN , MATTHIAS KOERNER , BERND KUHN , JENS-UWE PETERS , MARKUS RUDOLPH

发明人： DANIELA ALBERATI , RUBÉN ALVAREZ SÁNCHEZ , KONRAD BLEICHER , ALEXANDER FLOHR , KATRIN GROEBKE ZBINDEN , MATTHIAS KOERNER , BERND KUHN , JENS-UWE PETERS , MARKUS RUDOLPH

IPC分类号： A61K31/437 , A61K31/5377 , C07D519/00 , A61K31/4985 , A61K31/553 , A61P25/22 , A61K31/541 , A61P25/18 , A61P25/28 , A61P25/24 , A61P25/30 , C07D471/04 , A61K31/496

CPC分类号： C07D471/04 , A61K31/437 , A61K31/496 , A61K31/5025 , A61K31/5377 , A61K31/553 , C07D487/04

摘要： The invention is concerned with novel imidazopyridine derivatives of formula (I) wherein R1, R2, R3, R4, R5 and A are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used for the treatment of various diseases, including central nervous system disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia.